Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL By Ogkologos - December 12, 2024 765 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Sotorasib Shows Promising Activity and Acceptable Safety in Patients with Previously... January 10, 2023 Darolutamide in Combination with ADT and Docetaxel Increases Overall Survival in... February 27, 2023 Marginal Benefit in Overall and Progression-Free Survival from New Anticancer Drugs August 12, 2022 Insulin Resistance May Contribute to Poorer Breast Cancer Outcomes, Study Says June 2, 2020 Load more HOT NEWS Cancerul în comunitatea mea: progresul îngrijirilor pentru cancer în România Implementation of Molecular Tumour Board Portal Developed Under the Umbrella of... How Early Cancer Detection and Diagnosis Saved My Life Twice: A... What to Know About Using Activated Charcoal During Cancer
